Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Betahistidine |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Benzoquinonium |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Chlorisondamine |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Pentolinium |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Mebutamate |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Trimethidinium |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Hexamethonium |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Tienilic acid |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Pentamethonium bromide |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Protoveratrine A |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Cryptenamine |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Angiotensin-converting enzyme inhibitor |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Centrally acting hypotensive agent (substance) |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Vasodilator (substance) |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Mecamylamine (substance) |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Nitroprusside (substance) |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Rauwolfia alkaloid (substance) |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Angiotensin II receptor antagonist |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Pargyline (substance) |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Trimetaphan |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
médicament antihypertenseur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adrenergic neurone blocking drug poisoning |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Amiloride and loop diuretic adverse reaction |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Antihypertensive adverse reaction |
Causative agent (attribute) |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Adrenergic neurone blocking drug adverse reaction |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Ganglion-blocking drug adverse reaction |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Trimetaphan adverse reaction |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Amiloride and loop diuretic allergy |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Antihypertensive allergy |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adrenergic neurone blocking drug allergy |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Ganglion-blocking drug allergy |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Allergy to trimethaphan |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Antihypertensive overdose |
Causative agent (attribute) |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Adrenergic neurone blocking drug overdose |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Accidental antihypertensive overdose |
Causative agent (attribute) |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Intentional antihypertensive overdose |
Causative agent (attribute) |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Antihypertensive overdose of undetermined intent |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
fœtus ou nouveau-né affecté par l'usage maternel de médicament antihypertenseur |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Calcium-channel blocker+angiotensin-converting enzyme inhibitor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing felodipine and ramipril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Felodipine 2.5 mg and ramipril 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Felodipine 5 mg and ramipril 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Centrally acting antihypertensive drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing adrenergic neurone blocker (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing bethanidine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely betanidine 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing ganglion blocker (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Trimetaphan camsylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
camsilate de trimétaphan 50 mg/mL, ampoule de 5 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Other antihypertensives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Antihypertensives+barbiturates |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing betanidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing trimetaphan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Angiotensin II receptor antagonist+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
olmésartan médoxomil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing olmesartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Olmesartan medoxomil 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Deserpidine (substance) |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Guanethidine (substance) |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Metirosine |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Bethanidine sulfate |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Imidazoline receptor agonist |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Debrisoquine (substance) |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing angiotensin-converting enzyme inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing angiotensin II receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Product containing eplerenone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to reserpine |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to other antihypertensives |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to antihypertensives NOS |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Eplerenone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Eplerenone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Inspra 50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Inspra 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Eplerenone 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Inspra 100mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Angiotensin II receptor antagonist adverse reaction (disorder) |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Hydrochlorothiazide 12.5 mg and telmisartan 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Olmesartan medoxomil 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Eplerenone (substance) |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to ganglion blocking drug |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to pentamethonium bromide |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to trimetaphan camsylate |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Adverse reaction to ganglion blockers NOS |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Substance with beta adrenergic receptor antagonist mechanism of action (substance) |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Fetal captopril/enalapril syndrome |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
3 |
Ganglion blocking agent |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Betanidine |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Ivabradine (substance) |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Poisoning caused by antihypertensive agent |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Adrenergic neurone blocking drug poisoning |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
[X]Poisoning by other antihypertensive drugs, not elsewhere classified |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Renin inhibitor |
Is a |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Ketanserin |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Antihypertensive allergy |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Adrenergic neurone blocking drug allergy |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Losartan allergy |
Causative agent (attribute) |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
1 |
Product containing renin inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|
Endothelin receptor antagonist |
Is a |
True |
Hypotensive agent (substance) |
Inferred relationship |
Some |
|